The MPP Association conducted a survey to gather feedback from key companies in the combined product sector. The data is presented in this report, which highlights the existing challenges in the regulatory process applicable to integral and non-integral drug-device combination products, such as single-use integral drug-device combination products, co-packaged products, and referenced products.
